Evidence map›Paper›PMID 38444605›Full record

ArticleiScience2024

Lineage tracing reveals transient phenotypic adaptation of tubular cells during acute kidney injury.

Marc Buse, Mingbo Cheng, Vera Jankowski, Michaela Lellig, Viktor Sterzer, Thiago Strieder, Katja Leuchtle, Ina V Martin, Claudia Seikrit, Paul Brinkkoettter and 9 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Toward a CRISPR-based mouse model ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Marc BuseDivision of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany.
Mingbo ChengInstitute for Computational Genomics, RWTH Aachen University Hospital, Aachen, Germany.
Vera JankowskiInstitute for Molecular Cardiovascular Research, RWTH Aachen University Hospital, Aachen, Germany.
Michaela LelligInstitute for Molecular Cardiovascular Research, RWTH Aachen University Hospital, Aachen, Germany.
Viktor SterzerDivision of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany.
Thiago StriederDivision of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany.
Katja LeuchtleDivision of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany.
Ina V MartinDivision of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany.
Claudia SeikritDivision of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany.
Paul BrinkkoettterDepartment II of Internal Medicine and Centre for Molecular Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Giuliano CrispatzuDepartment II of Internal Medicine and Centre for Molecular Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Jürgen FloegeDivision of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany.
Peter BoorDivision of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany.
Timotheus SpeerMedical Clinic 4, Nephrology, University of Frankfurt und Goethe-University Frankfurt, Frankfurt am Main, Germany.
Rafael KramannDivision of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany.
Tammo OstendorfDivision of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany.
Marcus J MoellerDivision of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany.
Ivan G CostaInstitute for Computational Genomics, RWTH Aachen University Hospital, Aachen, Germany.
Eleni StamellouDivision of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany.
RWTH Aachen University · DEUniversitätsklinikum Aachen · DEUniversity Hospital Cologne · DEUniversity Hospital Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tubular injury is the hallmark of acute kidney injury (AKI) with a tremendous impact on patients and health-care systems. During injury, any differentiated proximal tubular cell (PT) may transition into a specific injured phenotype, so-called "scattered tubular cell" (STC)-phenotype. To understand the fate of this specific phenotype, we generated transgenic mice allowing inducible, reversible, and irreversible tagging of these cells in a murine AKI model, the unilateral ischemia-reperfusion injury (IRI). For lineage tracing, we analyzed the kidneys using single-cell profiling during disease development at various time points. Labeled cells, which we defined by established endogenous markers, already appeared 8 h after injury and showed a distinct expression set of genes. We show that STCs re-differentiate back into fully differentiated PTs upon the resolution of the injury. In summary, we show the dynamics of the phenotypic transition of PTs during injury, revealing a reversible transcriptional program as an adaptive response during disease.

Indexed as

Cell biologyNephrology

Identifiers

PMID38444605
PMCPMC10914483
OpenAlexW4391888131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.